Curative Effect and Cost-effectiveness of Traditional Chinese Medicine and Immunomodulator in Adjuvant Treatment of Retreatment Pulmonary Tuberculosis
王怀冲,徐颖颖,张相彩,王翠莲,曹佳薇,何俏军
DOI: https://doi.org/10.3969/j.issn.1007-9572.2014.06.029
2014-01-01
Chinese General Practice
Abstract:Objective To evaluate the curative effect and cost-effectiveness of traditional Chinese medicine(TCM) and immunomodulator in adjuvant treatment of retreatment pulmonary tuberculosis,and to find out a best therapeutic scheme.Methods A total of 307 patients with recrudescent and sputum bacilli positive who were treated in inpatient and outpatient department of integrated Chinese and Western Medicine Hospital of Zhejiang Province,were randomly divided into three groups by random number table method,99 cases in control group,105 cases in TCM group,and 103 cases in immunomodulator group.Three groups of patients received intensive treatment for 3 months,then received consolidation treatment for 5 months.Cases in control group were treated by a regimen of 3HL2ZV /5HL2V(H:isoniazid,L2:rifapentine,Z:pyrazinamide,V:levofloxacin),cases in the TCM group were treated by a regimen of 3HL2ZV /5HL2V and Kangfuxin liquid(10 ml every time,3 times per day,oral administration),cases in the immunomodulator group were treated by a regimen of 3HL2ZV /5HL2V and Mycobacterium vaccine(2.5 μg every time,1 time every 2 weeks,intramuscular injection).Clinical efficacy and adverse reactions were observed and recorded among three groups.The cost-effectiveness in three groups was evaluated by pharmacoeconomic method.Results The sputum bacilli negative conversion rate in control group,TCM group and immunomodulator group were 80.8%(80 /99),93.3%(98 /105),92.2%(95 /103) respectively,the rate in TCM group was higher than that of the control group(P 0.016 7).There was no significant difference in focus absoption rate and cavity closure rate among three groups(P 0.05).The clinical symptoms disappear percentages in control group,TCM group and immunomodulator group were24.8%(84 /339),65.4%(287 /439) and 62.3%(259 /416) respectively,the percentages in TCM group and immunomodulator group were significantly higher than that in control group(χ2= 126.376 and 105.844,respectively,P 0.016 7).There was no significant difference in clinical symptoms disappear percentage between TCM group and immunomodulator group(χ2= 0.289,P 0.016 7).The incidences of adverse reaction in control group,TCM group and immunomodulator group were45.5%(45 /99),33.3%(35 /105) and 38.8%(40 /103),respectively.There was no significant difference in the incidence of adverse reaction among three groups(χ2= 3.149,P 0.05).The costs in TCM group,immunomodulator group and control group were 10 485.5,8 734.4,7 832.3 yuan,respectively.The increment costs of cost-effectiveness in TCM group and immunomodulator group were 212.3,79.1 yuan.Conclusion The TCM can accelerate sputum bacilli negative conversion,no growth adverse reactions.According to cost-effectiveness analysis,the costs in immunomodulator group can be controlled more effectively than that in TCM group.